Cargando…
Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by dysregulation of the immune system, vascular damage, and fibrosis of the skin and internal organs. Patients with SSc show a heterogeneous phenotype and a range of clinical courses. Therefore, biomarkers that are helpful for pr...
Autores principales: | Utsunomiya, Akira, Oyama, Noritaka, Hasegawa, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690387/ https://www.ncbi.nlm.nih.gov/pubmed/33105647 http://dx.doi.org/10.3390/jcm9113388 |
Ejemplares similares
-
A Case of Erythema Multiforme Major Developed after Sequential Use of Two Immune Checkpoint Inhibitors, Nivolumab and Ipilimumab, for Advanced Melanoma: Possible Implication of Synergistic and/or Complementary Immunomodulatory Effects
por: Utsunomiya, Akira, et al.
Publicado: (2018) -
A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis
por: Kasamatsu, Hiroshi, et al.
Publicado: (2023) -
Lichen Sclerosus: A Current Landscape of Autoimmune and Genetic Interplay
por: Oyama, Noritaka, et al.
Publicado: (2022) -
Erythema annulare centrifugum in the setting of COVID‐19 infection: A case report and literature review
por: Fujisaki, Misako, et al.
Publicado: (2022) -
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
por: Affandi, Alsya J., et al.
Publicado: (2015)